Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Abiraterone acetate (Primary) ; Dasatinib (Primary) ; Sunitinib (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 05 Jan 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 21 Sep 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.